An expert discusses the MARIPOSA study’s impact on managing central nervous system (CNS) involvement in EGFR-mutated non–small cell lung cancer, emphasizing improved brain progression-free survival, ...

This radical coaching method was once a secret. Now, it’s reimagining athletic training and powering champions all over the ...

Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the Company ...

GLP study marks a key milestone in Autonomix's path to achieve regulatory approvals Company remains on track to submit ...

Study in fission yeast revealed a key role for a set of enzymes called agmatinases, which break down the metabolite agmatine into polyamines.

Applied Therapeutics stated it is still awaiting official meeting minutes from the FDA to determine next steps for the drug, which is being developed to treat CMT-SORD, a rare hereditary neuropathy ...

Our diet directly influences the clarity of our mind. A recent study sheds light on the cellular mechanisms by which high-fat ...

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout ...

Late last week, two days after an immigration judge granted him legal status through the asylum process, a correctional ...

Lean Body Mass: Improvements in lean body mass were aligned with total weight gains, suggesting preservation or accrual of muscle, consistent with pre-clinical research with ART27.13. Activity: ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company, today announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has granted Orphan Drug designation for DYNE-251 in ...

Applied Therapeutics (NASDAQ:APLT) saw its stock dive 55% in premarket trading Monday after the company disclosed uncertainty ...